• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中肺动脉高压的早期检测:一项法国全国性前瞻性多中心研究。

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

作者信息

Hachulla Eric, Gressin Virginie, Guillevin Loïc, Carpentier Patrick, Diot Elisabeth, Sibilia Jean, Kahan André, Cabane Jean, Francès Camille, Launay David, Mouthon Luc, Allanore Yannick, Tiev Kiet Phong, Clerson Pierre, de Groote Pascal, Humbert Marc

机构信息

Hôpital Claude-Huriez, Lille, France.

出版信息

Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433.

DOI:10.1002/art.21433
PMID:16320330
Abstract

OBJECTIVE

Screening allows for early management of pulmonary arterial hypertension (PAH), a severe complication of systemic sclerosis (SSc). Since no consensus has been reached on the method and criteria for optimal screening, we sought to develop an algorithm based on symptoms, Doppler echocardiography, and right heart catheterization (RHC) for application to a nationwide multicenter SSc population in France.

METHODS

This prospective study was conducted from September 2002 to July 2003 by experts at 21 SSc centers. At each center, SSc patients without severe pulmonary function abnormalities underwent Doppler echocardiography by an experienced cardiologist. Patients with a peak velocity of tricuspid regurgitation (VTR) of >3 meters/second or 2.5-3 meters/second with unexplained dyspnea were asked to undergo RHC to confirm PAH according to international guidelines.

RESULTS

Of the 599 patients analyzed, 29 had known PAH and 33 had suspected PAH, based on Doppler echocardiography, and underwent RHC. Of these 33, 18 were found to have PAH, 3 had left ventricular dysfunction, and 12 had no PAH. Newly diagnosed cases of PAH were of mild severity (mean +/- SD pulmonary artery pressure [mPAP] 30 +/- 9 mm Hg, mean +/- SD total pulmonary resistance [TPR] 524 +/- 382 dynes x second/cm(5)). Hemodynamic findings in patients with known PAH were mPAP 49 +/- 17 mm Hg and TPR 1,007 +/- 615 dynes x second/cm(5). The estimate of PAH prevalence was 7.85% (95% confidence interval 5.70-10.00).

CONCLUSION

This screening algorithm, based on dyspnea, Doppler echocardiographic evaluation of VTR, and RHC, enabled early detection of PAH at a mild stage. Whether mild PAH will evolve to severe PAH in reported cases and whether this early diagnosis translates into improved prognosis for patients with mild PAH will be evaluated in the ongoing 3-year followup of this cohort.

摘要

目的

筛查有助于对肺动脉高压(PAH)进行早期管理,PAH是系统性硬化症(SSc)的一种严重并发症。由于在最佳筛查方法和标准上尚未达成共识,我们试图基于症状、多普勒超声心动图和右心导管检查(RHC)开发一种算法,以应用于法国全国范围内的多中心SSc人群。

方法

这项前瞻性研究由21个SSc中心的专家于2002年9月至2003年7月进行。在每个中心,没有严重肺功能异常的SSc患者由经验丰富的心脏病专家进行多普勒超声心动图检查。三尖瓣反流峰值速度(VTR)>3米/秒或2.5 - 3米/秒且伴有无法解释的呼吸困难的患者,根据国际指南被要求进行RHC以确诊PAH。

结果

在分析的599例患者中,基于多普勒超声心动图,29例已知患有PAH,33例疑似患有PAH并接受了RHC检查。在这33例患者中,18例被发现患有PAH,3例有左心室功能障碍,12例没有PAH。新诊断出的PAH病例病情较轻(平均±标准差肺动脉压[mPAP] 30±9毫米汞柱,平均±标准差总肺阻力[TPR] 524±382达因×秒/厘米⁵)。已知患有PAH的患者的血流动力学结果为mPAP 49±17毫米汞柱和TPR 1007±615达因×秒/厘米⁵。PAH患病率估计为7.85%(95%置信区间5.70 - 10.00)。

结论

这种基于呼吸困难、VTR的多普勒超声心动图评估和RHC的筛查算法能够在轻度阶段早期检测出PAH。在该队列正在进行的3年随访中,将评估报告病例中轻度PAH是否会发展为重度PAH,以及这种早期诊断是否会改善轻度PAH患者的预后。

相似文献

1
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.系统性硬化症中肺动脉高压的早期检测:一项法国全国性前瞻性多中心研究。
Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433.
2
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.在法国一项全国性多中心纵向研究中,系统性硬化症相关肺动脉高压的三年发病率。
Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525.
3
Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.使用临床和超声心动图标准评估系统性硬化症患者的肺动脉高压
Am J Med Sci. 2016 Oct;352(4):343-347. doi: 10.1016/j.amjms.2016.07.007. Epub 2016 Jul 16.
4
Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.DETECT 算法在系统性硬皮病肺动脉高压风险检测中的应用:来自捷克一家三级中心的数据。
Rheumatology (Oxford). 2016 Jan;55(1):109-14. doi: 10.1093/rheumatology/kev327. Epub 2015 Aug 28.
5
[Pulmonary arterial hypertension in systemic sclerosis: definition of a screening algorithm for early detection (the ItinérAIR-Sclérodermie Study)].[系统性硬化症中的肺动脉高压:早期检测筛查算法的定义(ItinérAIR-Sclérodermie研究)]
Rev Med Interne. 2004 May;25(5):340-7. doi: 10.1016/j.revmed.2004.01.019.
6
Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.在一项系统性硬化症患者多中心研究中,通过超声心动图测量的肺动脉压力升高的患病率。
J Rheumatol. 2005 Jul;32(7):1273-8.
7
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis.在一个全国性大型多中心系统性硬化症患者队列中,通过多普勒超声心动图评估心脏异常情况。
Ann Rheum Dis. 2008 Jan;67(1):31-6. doi: 10.1136/ard.2006.057760. Epub 2007 Jan 31.
8
Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.超声心动图在系统性硬化症患者肺动脉压过度升高中的应用价值。
Kardiol Pol. 2011;69(1):9-15.
9
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.当前抗逆转录病毒治疗时代与HIV相关的肺动脉高压患病率。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):108-13. doi: 10.1164/rccm.200704-541OC. Epub 2007 Oct 11.
10
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.基于证据的系统性硬化症肺动脉高压检测:DETECT 研究。
Ann Rheum Dis. 2014 Jul;73(7):1340-9. doi: 10.1136/annrheumdis-2013-203301. Epub 2013 May 18.

引用本文的文献

1
Cardiac magnetic resonance in systemic sclerosis: imaging features and potential prognostic implications. A literature review.系统性硬化症的心脏磁共振成像:影像学特征及潜在预后意义。文献综述。
Front Med (Lausanne). 2025 Aug 15;12:1606593. doi: 10.3389/fmed.2025.1606593. eCollection 2025.
2
Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.结缔组织病相关肺动脉高压的患病率、分子机制及诊断方法
Rheumatol Int. 2025 Apr 4;45(4):87. doi: 10.1007/s00296-025-05845-z.
3
Cardiopulmonary Exercise Testing: Deciphering Cardiovascular Complications in Systemic Sclerosis.
心肺运动试验:解读系统性硬化症中的心血管并发症
Rev Cardiovasc Med. 2025 Jan 21;26(1):25914. doi: 10.31083/RCM25914. eCollection 2025 Jan.
4
A combination of clinical, electrocardiographic, and echocardiographic parameters predicts pulmonary hypertension occurrence in patients with end-stage renal disease.临床、心电图和超声心动图参数相结合可预测终末期肾病患者肺动脉高压的发生。
Front Cardiovasc Med. 2024 Nov 18;11:1337243. doi: 10.3389/fcvm.2024.1337243. eCollection 2024.
5
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.TAPSE/sPAP比值对系统性硬化症合并肺动脉高压患者心血管事件和死亡率的预测作用。
Front Cardiovasc Med. 2024 Oct 14;11:1430903. doi: 10.3389/fcvm.2024.1430903. eCollection 2024.
6
High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up.系统性硬化症的高分辨率计算机断层扫描:从诊断到随访
Rheumatol Immunol Res. 2024 Oct 21;5(3):166-174. doi: 10.2478/rir-2024-0023. eCollection 2024 Sep.
7
Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.系统性硬化症中的脂膜炎性硬化症与肺动脉高压
JAMA Dermatol. 2024 Dec 1;160(12):1329-1333. doi: 10.1001/jamadermatol.2024.3929.
8
Towards a Better Prognosis in Patients with Systemic Sclerosis-Related Pulmonary Arterial Hypertension: Recent Developments and Perspectives.改善系统性硬化症相关肺动脉高压患者的预后:最新进展与展望
J Clin Med. 2024 Sep 30;13(19):5834. doi: 10.3390/jcm13195834.
9
Early detection of pulmonary arterial hypertension through [F] positron emission tomography imaging with a vascular endothelial receptor small molecule.通过使用血管内皮受体小分子的[F]正电子发射断层扫描成像早期检测肺动脉高压。
Pulm Circ. 2024 Jul 26;14(3):e12393. doi: 10.1002/pul2.12393. eCollection 2024 Jul.
10
Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists.系统性硬化症患者肺动脉高压筛查的态度与障碍:对英国风湿病学家的一项调查
J Scleroderma Relat Disord. 2024 Jun;9(2):99-109. doi: 10.1177/23971983241235708. Epub 2024 Mar 13.